ANAPTYSBIO, INC — Director's Dealing 2017

Jan 26, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-01-25

Reporting Person: RENTON HOLLINGS (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Director Stock Option (right to buy)	$6.93	2025-07-05	Common Stock (40925)		Direct
Director Stock Option (right to buy)	$6.93	2025-08-13	Common Stock (10231)		Direct

Footnotes

F1: The stock option vested and became exercisable in 36 equal monthly installments beginning on July 23, 2015, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.

F2: The stock option vested and became exercisable in 36 equal monthly installments beginning on August 6, 2015, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.